Advertisement
Screener

VERICEL CORPORATION (VCEL) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

VERICEL CORPORATION Stock-Based Compensation

VERICEL CORPORATION (VCEL) reported Stock-Based Compensation of $20.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-07-30

  • VERICEL CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $9.08M, a 10.42% decline year-over-year.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $11.29M, a 1.83% decline year-over-year.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $8.42M, a 6.39% increase year-over-year.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $8.70M, a 5.69% decline year-over-year.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for fiscal 2025 was $38.77M, a 6.23% increase from fiscal 2024.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for fiscal 2024 was $36.49M, a 12.90% increase from fiscal 2023.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for fiscal 2023 was $32.33M, a 13.07% decline from fiscal 2022.
  • VERICEL CORPORATION share-based payment arrangement, noncash expense for fiscal 2022 was $37.18M, a 8.34% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 267 monthShare-based Payment Arrangement, Noncash Expense 270 monthShare-based Payment Arrangement, Noncash Expense 273 monthShare-based Payment Arrangement, Noncash Expense 276 monthShare-based Payment Arrangement, Noncash Expense 279 monthShare-based Payment Arrangement, Noncash Expense 282 monthShare-based Payment Arrangement, Noncash Expense 285 monthShare-based Payment Arrangement, Noncash Expense 288 monthShare-based Payment Arrangement, Noncash Expense 291 monthShare-based Payment Arrangement, Noncash Expense 294 monthShare-based Payment Arrangement, Noncash Expense 297 monthShare-based Payment Arrangement, Noncash Expense 300 month
2026-06-30$9.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$20.38M
10-Q · filed 2026-07-30
$28.80M
derived: sum of 3 quarters · filed 2026-07-30
$37.50M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$11.29M
10-Q · filed 2026-05-07
$19.72M
derived: sum of 2 quarters · filed 2026-05-07
$28.42M
derived: sum of 3 quarters · filed 2026-05-07
$38.56M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$8.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$17.12M
derived: sum of 2 quarters · filed 2026-02-26
$27.26M
derived: sum of 3 quarters · filed 2026-07-30
$38.77M
10-K · filed 2026-02-26
2025-09-30$8.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$18.84M
derived: sum of 2 quarters · filed 2026-07-30
$30.34M
10-Q · filed 2025-11-06
$38.26M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$10.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$21.64M
10-Q · filed 2026-07-30
$29.56M
derived: sum of 3 quarters · filed 2026-07-30
$38.79M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$11.51M
10-Q · filed 2026-05-07
$19.42M
derived: sum of 2 quarters · filed 2026-05-07
$28.65M
derived: sum of 3 quarters · filed 2026-05-07
$38.17M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$7.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$17.14M
derived: sum of 2 quarters · filed 2026-02-26
$26.66M
derived: sum of 3 quarters · filed 2026-02-26
$36.49M
10-K · filed 2026-02-26
2024-09-30$9.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$18.74M
derived: sum of 2 quarters · filed 2025-11-06
$28.58M
10-Q · filed 2025-11-06
$35.49M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$9.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$19.35M
10-Q · filed 2025-07-31
$26.26M
derived: sum of 3 quarters · filed 2026-02-26
$34.19M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$9.83M
10-Q · filed 2025-05-08
$16.74M
derived: sum of 2 quarters · filed 2026-02-26
$24.67M
derived: sum of 3 quarters · filed 2026-02-26
$33.43M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$6.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$14.83M
derived: sum of 2 quarters · filed 2026-02-26
$23.59M
derived: sum of 3 quarters · filed 2026-02-26
$32.33M
10-K · filed 2026-02-26
2023-09-30$7.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$16.68M
derived: sum of 2 quarters · filed 2024-11-07
$25.42M
10-Q · filed 2024-11-07
$33.16M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$8.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
$17.49M
10-Q · filed 2024-08-01
$25.23M
derived: sum of 3 quarters · filed 2025-02-27
$34.34M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$8.73M
10-Q · filed 2024-05-08
$16.47M
derived: sum of 2 quarters · filed 2025-02-27
$25.57M
derived: sum of 3 quarters · filed 2025-02-27
$36.38M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$7.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$16.84M
derived: sum of 2 quarters · filed 2025-02-27
$27.65M
derived: sum of 3 quarters · filed 2025-02-27
$37.18M
10-K · filed 2025-02-27
2022-09-30$9.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$19.91M
derived: sum of 2 quarters · filed 2023-11-08
$29.44M
10-Q · filed 2023-11-08
$37.28M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$10.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$20.34M
10-Q · filed 2023-08-02
$28.18M
derived: sum of 3 quarters · filed 2024-02-29
$36.78M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$9.53M
10-Q · filed 2023-05-10
$17.37M
derived: sum of 2 quarters · filed 2024-02-29
$25.97M
derived: sum of 3 quarters · filed 2024-02-29
$36.83M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$7.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$16.44M
derived: sum of 2 quarters · filed 2024-02-29
$27.30M
derived: sum of 3 quarters · filed 2024-02-29
$34.32M
10-K · filed 2024-02-29
2021-09-30$8.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$19.46M
derived: sum of 2 quarters · filed 2022-11-09
$26.48M
10-Q · filed 2022-11-09
$29.50M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$10.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03
$17.89M
10-Q · filed 2022-08-03
$20.91M
derived: sum of 3 quarters · filed 2023-02-23
$23.58M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$7.02M
10-Q · filed 2022-05-04
$10.04M
derived: sum of 2 quarters · filed 2023-02-23
$12.72M
derived: sum of 3 quarters · filed 2023-02-23
$17.09M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
$5.70M
derived: sum of 2 quarters · filed 2023-02-23
$10.07M
derived: sum of 3 quarters · filed 2023-02-23
$13.84M
10-K · filed 2023-02-23
2020-09-30$2.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$7.05M
derived: sum of 2 quarters · filed 2021-11-09
$10.82M
10-Q · filed 2021-11-09
$13.90M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$4.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
$8.14M
10-Q · filed 2021-08-04
$11.23M
derived: sum of 3 quarters · filed 2022-02-24
$14.51M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$3.77M
10-Q · filed 2021-05-05
$6.85M
derived: sum of 2 quarters · filed 2022-02-24
$10.14M
derived: sum of 3 quarters · filed 2022-02-24
$14.32M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$3.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$6.37M
derived: sum of 2 quarters · filed 2022-02-24
$10.55M
derived: sum of 3 quarters · filed 2022-02-24
$13.18M
10-K · filed 2022-02-24
2019-09-30$3.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$7.47M
derived: sum of 2 quarters · filed 2020-11-05
$10.10M
10-Q · filed 2020-11-05
$11.58M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$4.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$6.81M
10-Q · filed 2020-08-05
$8.29M
derived: sum of 3 quarters · filed 2021-02-24
$10.23M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$2.63M
10-Q · filed 2020-05-11
$4.11M
derived: sum of 2 quarters · filed 2021-02-24
$6.04M
derived: sum of 3 quarters · filed 2021-02-24
$8.51M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$3.42M
derived: sum of 2 quarters · filed 2021-02-24
$5.88M
derived: sum of 3 quarters · filed 2021-02-24
$7.22M
10-K · filed 2021-02-24
2018-09-30$1.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$4.40M
derived: sum of 2 quarters · filed 2019-11-05
$5.74M
10-Q · filed 2019-11-05
$6.37M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$2.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$3.81M
10-Q · filed 2019-08-06
$4.43M
derived: sum of 3 quarters · filed 2020-02-25
$5.19M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$1.34M
10-Q · filed 2019-05-07
$1.97M
derived: sum of 2 quarters · filed 2020-02-25
$2.72M
derived: sum of 3 quarters · filed 2020-02-25
$3.52M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$627.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$1.38M
derived: sum of 2 quarters · filed 2020-02-25
$2.18M
derived: sum of 3 quarters · filed 2020-02-25
$2.68M
10-K · filed 2020-02-25
2017-09-30$755.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$1.55M
derived: sum of 2 quarters · filed 2018-11-06
$2.05M
10-Q · filed 2018-11-06
$2.58M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$796.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
$1.30M
10-Q · filed 2018-08-06
$1.82M
derived: sum of 3 quarters · filed 2019-02-26
$2.48M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$502.00K
10-Q · filed 2018-05-08
$1.03M
derived: sum of 2 quarters · filed 2019-02-26
$1.68M
derived: sum of 3 quarters · filed 2019-02-26
$2.51M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$526.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$1.18M
derived: sum of 2 quarters · filed 2019-02-26
$2.01M
derived: sum of 3 quarters · filed 2019-02-26
$2.50M
10-K · filed 2019-02-26
2016-09-30$654.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$1.49M
derived: sum of 2 quarters · filed 2017-11-07
$1.97M
10-Q · filed 2017-11-07
$2.53M
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30$831.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$1.32M
10-Q · filed 2017-08-09
$1.88M
derived: sum of 3 quarters · filed 2018-03-05
$2.45M
derived: sum of 4 quarters · filed 2018-03-05
2016-03-31$488.00K
10-Q · filed 2017-05-10
$1.05M
derived: sum of 2 quarters · filed 2018-03-05
$1.62M
derived: sum of 3 quarters · filed 2018-03-05
$2.31M
derived: sum of 4 quarters · filed 2018-03-05
2015-12-31$559.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$1.13M
derived: sum of 2 quarters · filed 2018-03-05
$1.82M
derived: sum of 3 quarters · filed 2018-03-05
$2.75M
10-K · filed 2018-03-05
2015-09-30$574.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$1.27M
derived: sum of 2 quarters · filed 2016-11-07
$2.19M
10-Q · filed 2016-11-07
$2.37M
derived: sum of 4 quarters · filed 2017-03-13
2015-06-30$692.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$1.61M
10-Q · filed 2016-08-08
$1.80M
derived: sum of 3 quarters · filed 2017-03-13
$2.00M
derived: sum of 4 quarters · filed 2017-03-13
2015-03-31$922.00K
10-Q · filed 2016-05-10
$1.11M
derived: sum of 2 quarters · filed 2017-03-13
$1.31M
derived: sum of 3 quarters · filed 2017-03-13
$1.49M
derived: sum of 4 quarters · filed 2017-03-13
2014-12-31$186.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13
$388.00K
derived: sum of 2 quarters · filed 2017-03-13
$569.00K
derived: sum of 3 quarters · filed 2017-03-13
$839.00K
10-K · filed 2017-03-13
2014-09-30$202.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$383.00K
derived: sum of 2 quarters · filed 2015-11-13
$653.00K
10-Q · filed 2015-11-13
$1.05M
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30$181.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12
$451.00K
10-Q · filed 2015-08-12
$849.00K
derived: sum of 3 quarters · filed 2016-03-14
$994.00K
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31$270.00K
10-Q · filed 2015-05-14
$668.00K
derived: sum of 2 quarters · filed 2016-03-14
$813.00K
derived: sum of 3 quarters · filed 2016-03-14
$1.24M
derived: sum of 4 quarters · filed 2016-03-14
$18.69M
10-Q · filed 2014-05-15
2013-12-31$398.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$543.00K
derived: sum of 2 quarters · filed 2016-03-14
$969.00K
derived: sum of 3 quarters · filed 2016-03-14
$926.00K
10-K · filed 2016-03-14
$18.42M
10-K · filed 2014-03-13
2013-09-30$145.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$571.00K
derived: sum of 2 quarters · filed 2014-11-13
$528.00K
10-Q · filed 2014-11-13
$972.00K
derived: sum of 4 quarters · filed 2015-03-25
$18.02M
10-Q · filed 2013-11-12
2013-06-30$426.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$383.00K
10-Q · filed 2014-08-14
$827.00K
derived: sum of 3 quarters · filed 2015-03-25
$1.95M
derived: sum of 4 quarters · filed 2015-03-25
$17.88M
10-Q · filed 2013-08-07
2013-03-31-$43.00K
10-Q · filed 2014-05-15
$401.00K
derived: sum of 2 quarters · filed 2015-03-25
$1.53M
derived: sum of 3 quarters · filed 2015-03-25
$2.75M
derived: sum of 4 quarters · filed 2015-03-25
$17.45M
10-Q · filed 2013-05-08
2012-12-31$444.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25
$1.57M
derived: sum of 2 quarters · filed 2015-03-25
$2.79M
derived: sum of 3 quarters · filed 2015-03-25
$3.61M
10-K · filed 2015-03-25
$17.50M
10-K · filed 2013-03-18
2012-09-30$1.13M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$2.35M
derived: sum of 2 quarters · filed 2013-11-12
$3.17M
10-Q · filed 2013-11-12
$4.14M
derived: sum of 4 quarters · filed 2014-03-13
$17.05M
10-Q · filed 2012-11-08
2012-06-30$1.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
$2.04M
10-Q · filed 2013-08-07
$3.02M
derived: sum of 3 quarters · filed 2014-03-13
$3.93M
derived: sum of 4 quarters · filed 2014-03-13
$15.92M
10-Q · filed 2012-08-07
2012-03-31$815.00K
10-Q · filed 2013-05-08
$1.79M
derived: sum of 2 quarters · filed 2014-03-13
$2.71M
derived: sum of 3 quarters · filed 2014-03-13
$3.94M
derived: sum of 4 quarters · filed 2014-03-13
$14.70M
10-Q · filed 2012-05-10
2011-12-31$976.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$1.90M
derived: sum of 2 quarters · filed 2014-03-13
$3.13M
derived: sum of 3 quarters · filed 2014-03-13
$3.74M
10-K · filed 2014-03-13
$13.88M
10-K · filed 2012-03-15
2011-09-30$919.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$2.15M
derived: sum of 2 quarters · filed 2012-11-08
$2.77M
10-Q · filed 2012-11-08
$12.91M
10-Q · filed 2011-11-08
2011-06-30$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
$1.85M
10-Q · filed 2012-08-07
$11.99M
10-Q · filed 2011-08-15
2011-03-31$616.00K
10-Q · filed 2012-05-10
2010-12-31$1.04M
10-K · filed 2013-03-18
2010-09-30$485.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$845.00K
10-Q · filed 2011-11-08
2010-06-30$360.00K
10-Q · filed 2011-08-15
$710.00K
10-K · filed 2013-03-18
2009-06-30$1.36M
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80